Covered recipient · General Payments record
JADE LAW
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$5,075.02
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,643.08 | 56 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $169.90 | 7 |
| GENZYME CORPORATION | $161.22 | 4 |
| Acerta Pharma LLC | $158.62 | 2 |
| EMD Serono, Inc. | $102.50 | 3 |
| JAZZ PHARMACEUTICALS INC. | $99.20 | 3 |
| SERVIER PHARMACEUTICALS LLC | $97.91 | 4 |
| ABBVIE INC. | $87.91 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $62.36 | 2 |
| Celgene Corporation | $60.04 | 2 |
| Exelixis Inc. | $54.13 | 2 |
| Karyopharm Therapeutics Inc. | $53.57 | 2 |
| Janssen Biotech, Inc. | $49.74 | 2 |
| Merck Sharp & Dohme Corporation | $49.55 | 2 |
| Incyte Corporation | $47.96 | 2 |
| BeiGene USA, Inc. | $43.36 | 2 |
| Blueprint Medicines Corporation | $41.53 | 1 |
| Daiichi Sankyo Inc. | $39.22 | 2 |
| Regeneron Healthcare Solutions, Inc. | $38.75 | 1 |
| PFIZER INC. | $37.77 | 1 |
| Kite Pharma, Inc. | $34.06 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.87 | 1 |
| Aadi Bioscience, Inc. | $24.99 | 1 |
| ADC Therapeutics America, Inc. | $24.58 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.21 | 1 |
| Rigel Pharmaceuticals, Inc. | $19.69 | 1 |
| Immunocore Limited | $17.18 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (56)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.